Adenosine A2A Receptor in Bone Marrow-Derived Cells Mediated Macrophages M2 Polarization via PPARγ-P65 Pathway in

Ke-Jie Mou1, Kai-Feng Shen2, Yan-Ling Li3

  • 1Department of Neurosurgery, Bishan Hospital of Chongqing, Chongqing, China.

Insights

Adenosine A2A receptor (A2A R) signaling in bone marrow cells promotes M2 macrophage polarization and IL-10 production, offering neuroprotection in chronic cerebral hypoperfusion white matter damage.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • The role of adenosine A2A receptor (A2A R) in ischemic white matter damage from chronic cerebral hypoperfusion is unclear.
  • Investigating A2A R's role in macrophage polarization within white matter damage and its signaling pathways is crucial.

Purpose of the Study:

  • To elucidate the function of adenosine A2A receptor (A2A R) in macrophage polarization during chronic cerebral hypoperfusion-induced white matter damage.
  • To explore the underlying signaling mechanisms, including the PPARγ-P65 pathway.

Main Methods:

  • Utilized a mouse model of chronic cerebral hypoperfusion via bilateral common carotid artery stenosis.
  • Analyzed microglial/macrophage polarization in the corpus callosum using immunofluorescence.
  • Investigated macrophage polarization, gene expression (PPARγ, P65, IL-10, TNF-α, IL-1β), and signaling pathways in vitro using RAW264.7 cells.

Main Results:

  • A2A R knockout or inactivation in bone marrow cells exacerbated M1 marker expression in white matter lesions.
  • A2A R agonist treatment promoted M2 macrophage polarization, increasing PPARγ, P65, and IL-10 expression while decreasing TNF-α and IL-1β.
  • PPARγ knockdown abolished CGS21680-induced P65 and IL-10 upregulation but had less effect on TNF-α and IL-1β downregulation.

Conclusions:

  • A2A R signaling in bone marrow-derived cells drives M2 macrophage polarization and IL-10 production via the PPARγ-P65 pathway.
  • This mechanism contributes to the neuroprotective effects observed in white matter damage associated with chronic cerebral hypoperfusion.

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.3K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
2.6K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.9K